Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria. Franzen S, Smith JE, van den Berg E, Rivera Mindt M, et al. Alzheimers Dement 2021 Sep 30. doi: 10.1002/alz.12433.

Read + Share

Amedeo Smart

Independent Medical Education

Franzen S, Smith JE, van den Berg E, Rivera Mindt M, et al. Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria. Alzheimers Dement 2021 Sep 30. doi: 10.1002/alz.12433.
PMID: 34590409